Can B Corp (NASC) stock
Close on Oct 19, 2026Market cap $981.54KP/E –Yield –
Can B Corp saw revenue fall 57.7% to $1.03M over the twelve months to Sep 30, 2024. Free cash flow was -$1.32M. At the latest close the market valued the company at $981.54K.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2024
Valuation
- Market cap
- $981.54K
- P/E ratio
- –
- Price to sales
- 0.95
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -134.43%
Fundamentals
- Revenue
- $1.03M
- Net income
- -$13.26M
- EPS, diluted
- -$0.77
- Free cash flow
- -$1.32M
- Book value per share
- -$0.15
- Diluted shares
- 65M
Trading
- Previous close
- $0.02
- Open
- $0.01
- Day's range
- $0.01 – $0.01
- Volume
- 60,817
- Average volume (20 days)
- 75,608
Market cap history
Month-end market cap since 2016, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | NASC | S&P 500 | Difference | NASC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +44.2% | +0.6% | +43.6 pts | ||
| 3 months | +15.4% | +3.4% | +12.0 pts | ||
| Year to date | -7.0% | +13.3% | −20.3 pts | ||
| 1 year | -25.0% | +16.6% | −41.6 pts | ||
| 3 years | -78.6% | +86.4% | −164.9 pts | -40.2% | +23.1% |
| 5 years | -99.9% | +81.9% | −181.7 pts | -73.1% | +12.7% |
| 10 years | -100.0% | +318.9% | −418.8 pts | -61.5% | +15.4% |
Ten years at a glance
Fiscal years 2014 to 2023 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Can B filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Update
About Can B
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Can B Corp is a health and wellness company that develops, manufactures, and sells hemp-derived cannabinoid products and distributes durable medical equipment. Its product offerings include cannabidiol tinctures, topicals, capsules, and minor cannabinoid isolates and isomers, marketed under brands such as Canbiola and Pure Leaf Oil. The company also supplies durable medical devices, such as ultrasound therapy units and back support braces, intended to assist post-surgery recovery and pain relief. Its customers include retail consumers, medical professionals, doctor offices, and wholesale clients.
Company profile, executives and historyCan B stock: common questions
What is Can B's stock price?
NASC closed at $0.01 on Oct 19, 2026, down 1.32% on the day.
What is Can B's market cap?
Can B was worth $981.54K at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is NASC's P/E ratio?
Can B lost money over fiscal 2023 (diluted EPS -$0.77), so it has no meaningful P/E ratio.
How much revenue does Can B make?
Can B reported revenue of $1.03M for the twelve months to Sep 30, 2024, down 57.7% from a year earlier.
Does Can B pay a dividend?
No. Can B has not paid a cash dividend over the last twelve months.
How has NASC stock performed over the past year?
Including dividends, NASC returned -25.0% over the past year, against +16.6% for the S&P 500.
Who are Can B's competitors?
Companies most similar to Can B by business, industry and size include STEK, NUS, COSM, HLF, COR.
See a number that looks wrong?